Does ESR1 rs2234693 influence age at natural menopause?

The ESR1 rs2234693 polymorphism (PvuII) is a well-characterized genetic variant located in the first intron of the estrogen receptor alpha gene. While it significantly influences receptor expression and signaling dynamics, its relationship with the timing of reproductive aging is less direct than previously hypothesized.

Mechanistic impact on ESR1 expression

Research identifies rs2234693 as a functional cis-regulatory element that modulates estrogen receptor alpha (ER-alpha) activity.

• Transcriptional regulation: The T>C transition affects an intronic enhancer region, where the C allele (CC/TC genotypes) is associated with reduced ESR1 mRNA and protein expression compared to the T allele.
• Alternative splicing: The variant influences allele-specific mRNA isoform ratios by up to 10-fold and can lead to the production of truncated transcripts with dominant-negative activity on estrogen-response elements.

Impact on gonadotropin regulation

Variation in ER-alpha signaling is mechanistically linked to the regulation of the hypothalamic-pituitary-ovarian (HPO) axis through feedback loops.

• FSH and LH dynamics: ER-alpha mediates the negative feedback of estrogen on the pituitary. Decreased receptor expression or sensitivity can impair this feedback, contributing to fluctuations in follicle-stimulating hormone (FSH) and luteinizing hormone (LH).
• Clinical observations: Studies in perimenopausal women indicate that ESR1 polymorphisms are associated with estradiol fluctuations and the trajectory of menopausal symptoms, reflecting altered sensitivity to endocrine feedback.

Evidence regarding age at menopause

Despite the functional role of ESR1 in reproductive tissues, large-scale genetic evidence does not support rs2234693 as a primary determinant of the age at natural menopause (ANM).

• GWAS findings: Modern genome-wide association studies (GWAS) involving hundreds of thousands of women consistently identify DNA repair and immune pathways—rather than estrogen receptor variants—as the leading drivers of menopause timing.
• Study outcomes: Multiple cohort studies and meta-analyses have found no significant association between the rs2234693 genotype and ANM, with odds ratios often remaining near unity.

Bottom line

The ESR1 rs2234693 variant functionalizes differences in ER-alpha expression that influence hormonal feedback and symptom presentation; however, it is not a recognized clinical marker for predicting the age at menopause.